NTRA - ナテラ (Natera Inc.)

NTRAのニュース

   Prenatal Testing & Newborn Screening Market Research Report 2021 - ResearchAndMarkets.com  2021/07/16 11:35:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The market is expected to reach $8.018 billion in 2025 at a CAGR of 14%. Major players in the prenatal testing and newborn screening tests market are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera, Invitae, Centogene, Cradle Genomics, Roche Diagnostics, Quest Diagno
   Natera Inc (NTRA) CEO AND PRESIDENT Steven Leonard Chapman Sold $3.8 million of Shares  2021/07/08 22:15:05 GuruFocus
Related Stocks: NTRA ,
   Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value  2021/07/01 09:18:16 Seeking Alpha
   This Explosive Biotech Is Taking On a Huge New Market  2021/06/30 15:17:20 The Motley Fool
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
   Natera and BGI Genomics launch Signatera Assay in China  2021/06/24 13:33:07 Seeking Alpha
   Natera Inc (NTRA) CEO AND PRESIDENT Steven Leonard Chapman Sold $3.8 million of Shares  2021/07/08 22:15:05 GuruFocus
Related Stocks: NTRA ,
   Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value  2021/07/01 09:18:16 Seeking Alpha
   This Explosive Biotech Is Taking On a Huge New Market  2021/06/30 15:17:20 The Motley Fool
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
   Natera and BGI Genomics launch Signatera Assay in China  2021/06/24 13:33:07 Seeking Alpha
   Hedge Funds Arent Crazy About Natera Inc (NTRA) Anymore  2021/06/23 17:12:01 Yahoo Finance
In this article you are going to find out whether hedge funds think Natera Inc (NASDAQ:NTRA) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among []
   Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value  2021/07/01 09:18:16 Seeking Alpha
   This Explosive Biotech Is Taking On a Huge New Market  2021/06/30 15:17:20 The Motley Fool
Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.
   Natera and BGI Genomics launch Signatera Assay in China  2021/06/24 13:33:07 Seeking Alpha
   Hedge Funds Arent Crazy About Natera Inc (NTRA) Anymore  2021/06/23 17:12:01 Yahoo Finance
In this article you are going to find out whether hedge funds think Natera Inc (NASDAQ:NTRA) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among []
   Analyst Ratings For Natera  2021/06/22 15:50:13 Benzinga
Within the last quarter, Natera (NASDAQ: NTRA ) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1 0 Somewhat Bullish 1 3 1 0 Indifferent 0 0 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 9 analysts have offered 12-month price targets for Natera. The company has an average price target of $139.89 with a high of $160.00 and a low of $110.00. This current average represents a 8.44% increase from the previous average price target of $129.0. What Are Full story available on Benzinga.com

calendar